HIBT Lab! Immunai: Noam Solomon

HIBT Lab! Immunai: Noam Solomon

Up next

Advice Line with Ronnen Harary of Spin Master/PAW Patrol

Today’s callers: Ann from Nashville asks how to adapt her jewelry business in the face of rising gold prices. Then Felix in Martha’s Vineyard considers strategies for growing his family’s legacy honey and skincare company. Finally, Matt in Massachusetts seeks strategies for maint ...  Show more

e.l.f. Cosmetics: Joey Shamah. The Dollar Store Formula That Built a Cosmetics Giant

In 2004, Joey Shamah and his partner launched a cosmetics company built on an idea that made almost no sense:Sell high-quality makeup for just $1.At the time, high quality beauty products were supposed to be expensive. The biggest brands spent fortunes on celebrity endorsements, ...  Show more

Recommended Episodes

Immunai CTO and Co-Founder Luis Voloch on Using Deep Learning to Develop New Drugs - Ep. 176
NVIDIA AI Podcast

What if we could map our immune system to create drugs that can help our bodies win the fight against cancer and other diseases? That’s the big idea behind immunotherapy. The problem: the immune system is incredibly complex. Enter Immunai, a biotechnology company that’s using AI ...  Show more

A New Drug For A Relentless Brain Disease
Short Wave

ALS is a disease that destroys the nerve cells in the brain and spinal cord we need for voluntary movement. There is no cure, but now there is a newly approved medication that may slow down the disease and extend patients' lives. The drug, called Relyvrio, got its start with a co ...  Show more

Battling Pathogens and Building Immunity Begins In Your Gut – Dr. Robynne Chutkan : 998
The Human Upgrade: Biohacking for Longevity & Performance

IN THIS EPISODE OF THE HUMAN UPGRADE™… Robynne Chutkan, M.D., joins the show to talk about a topic that’s foundational to biohacking—resilience. More specifically, resilience that starts in the gut. You’ll learn:

<ul><li>how your microbiome continually ...  Show more

Antibiotics: How to fix a broken market
Business Daily

Antibiotics stopped providing big gains for pharmaceutical companies decades ago, but as bacteria become more resistant to drugs, the world needs new classes of antibiotics to be discovered if we want to prevent the next global health crisis.Dr Tina Joshi, Associate Professor of ...  Show more